Wednesday, 23 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Company
Deals
Fosun Pharma Partners with Soong Ching Ling Foundation for Women and Children’s Health
February 1, 2025
Company
Deals
Jumpcan Partners with Newsoara for PDE4 and Protease Inhibitors in China
February 1, 2025
Company
Novo Nordisk to Invest RMB 400M in Shanghai at CIIE
February 1, 2025
Company
Drug
Jiangsu Yahong Initiates Phase III Study for Hexvix in Bladder Cancer Detection
February 1, 2025
Company
Drug
Betta Pharmaceuticals’ BPI-452080 Accepted for Review by NMPA
February 1, 2025
Company
Drug
Qilu Regor’s RGT-264 Phosphate Tablets Approved for Phase I Study
February 1, 2025
Company
Deals
Hainan Free Trade Port to Simplify Drug Import Procedures
February 1, 2025
Policy / Regulatory
Hainan Free Trade Port to Simplify Drug Import Procedures
February 1, 2025
Company
Drug
Sinovac’s Varicella Vaccine Receives WHO Pre-Qualification
February 2, 2025
Company
Drug
Reforgene Medicine RM-001 Thalassemia Gene Editing
February 1, 2025
Company
Drug
Walvax Biotech Launches Phase IIIb Trial for mRNA COVID-19 Vaccine
February 1, 2025
Company
Drug
Guangdong Zhongsheng Initiates Phase III Study for RAY1216 in COVID-19
February 1, 2025
1
2
…
1,106
1,107
1,108
1,109
1,110
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?